Drawing for PHARMANUTRA

USPTO serial 79367749

PHARMANUTRA

Reviewed by CopyMark Law Group

Reg. 7567484Status 700Registered
Filing date
Status date
Registration date
Nov 19, 2024
Examiner
GLASSER, CARYN
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with PHARMANUTRA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Michelle E. Tochtrop

Michelle E. Tochtrop Chrisman Gallo Tochtrop LLC6509 Brecksville Road, #31550CLEVELAND, OH 44131-4854United States

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical and parapharmaceutical preparations for the treatment of gynecological, urological, gastroenterological, immunologic, cardiovascular, osteo-articular, and dermatological conditions and disorders; pharmaceutical preparations for oral hygiene being medicated oral care gels; pharmaceutical preparations for the treatment and relief of pain; hygienic products for medical and sanitary purposes, namely products and preparations for cleansing the skin for medical purposes; disinfectants; veterinary preparations for treating iron and vitamin deficiencies; dietetic substances for human use, namely, dietic foods and beverages adapted for medical purposes; food for babies; functional foods, namely, dietetic foods adapted for medical purposes; food supplements; dietary and nutritional supplements, including dietary and nutritional supplements containing at least one of the following compounds, namely, omega-3, omega-6, DHA, fatty acids, proteins, liposomes, vitamins, mineral salts, iron, microorganisms, lactic bacteria and prebiotic fibers; food supplements for medical use; vitamin and mineral supplements; hygienic preparations for medical use, namely disinfectants; pharmaceutical products for the care and hygiene of the eyes and eyelids, namely, eye drops, medicated eye and eyelid washes; ophthalmological and ophthalmic preparations; ointments, eye drops and disinfectant lotions for the care and hygiene of the eyes and eyelids, namely, pharmaceutical preparations for the treatment of eye diseases, eye drops, medicated eye washes; hygienic preparations for ophthalmological use, including sanitary solutions for the care of eyes and eyelids, namely medicated eye washes; wipes and bandages impregnated with ophthalmic and ophthalmological preparations for medical purposes; wipes impregnated with disinfectant lotion being disinfectant wipes; collyriums being medicated eye washes; antibiotics including antibiotics for ophthalmic use; medicinal sprays, gels, oils, creams, ointments and medicated lotions being medical preparations for treating pain, skin disorders; medicated sprays, gels, oils, creams, ointments and lotions for treating conditions of the nose, mouth, throat, eyes and ears; bandages for dressings; disinfectant bandages; adhesive strip bandages for medical purposes; adhesive patches for medical use being eye patches for medical purposes, adhesive bandages, surgical bandages; medicated plasters; transdermal patches featuring pharmaceuticals for the treatment of gynecological, urological, gastroenterological, immunologic, cardiovascular, dermatological, osteo-articular, and pain conditions, vitamins, caffeine for use as a stimulant; adhesive plasters for medical purposes; adhesive plasters and bandagesACTIVE—
035Wholesale and retail store services and online wholesale and retail store services for the benefit of others and mail order catalogues services featuring non-medicated plasters, bandages and dressings, adhesive plasters and bandages, plasters and bandages for orthopedic use and medical devices; business advice and consultancy relating to franchisingACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 3, 2025NREPNEW REPRESENTATIVE AT IB RECEIVED—
May 7, 2025TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
May 7, 2025ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 7, 2025REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
May 7, 2025CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
May 7, 2025COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
May 3, 2025FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Apr 14, 2025FICSFINAL DISPOSITION NOTICE SENT TO IB—
Apr 14, 2025FIMPFINAL DISPOSITION PROCESSED—
Feb 19, 2025FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Nov 19, 2024NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Nov 19, 2024R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Sep 30, 2024OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Sep 11, 2024OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Sep 11, 2024OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Sep 3, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Sep 3, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 15, 2024ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Aug 14, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Aug 1, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 2, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 2, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 2, 2024ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Jan 3, 2024GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Jan 3, 2024GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jan 3, 2024CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Dec 15, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Dec 14, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 14, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 1, 2023RFNTREFUSAL PROCESSED BY IB—
Jul 10, 2023RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jul 10, 2023RFRRREFUSAL PROCESSED BY MPU—
Jun 2, 2023RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jun 1, 2023CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 31, 2023DOCKASSIGNED TO EXAMINER—
May 2, 2023MAFRAPPLICATION FILING RECEIPT MAILED—
Apr 27, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 19, 2023LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED—
Apr 14, 2023SDRCSN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB—

Frequently asked questions

Related guidance